Why the evidence on nicotine still isn't reaching the people who need it
‍

‍

"It's not the nicotine that kills, it's the nasties in the smoke"

Cheryl K. Olson is a researcher who previously worked at Harvard Medical School. We spoke to her at WNC about the misperceptions that keep smokers from safer products. Her answers appear below in her own words.

Where do the misperceptions start?

"There's so many layers of misperceptions going on here. First, there's the concerns about nicotine. Is nicotine something that causes the disease, or is that tangential to the combustion? And we now know, I think most of us here know, that it's the combustion. I had a colleague from Britain say to me once, it's not the nicotine that kills, it's the nasties in the smoke. And I thought that was a beautiful way of putting it. I wanted to embroider that on a pillow."

And among clinicians?

"Health professionals have tremendous misconceptions. If we want them to even prescribe the nicotine replacement therapy medications, we have to get rid of that perception that nicotine might be dangerous. And then if you want to go to the next step … if you have patients who have failed with the medications and they keep relapsing to smoking and you want to save their lives, how can you recommend reduced-risk products? They often don't know what these products are because no one is explaining [them]."
"It's not the nicotine that kills, it's the nasties in the smoke."

Hear more from the people shaping this debate at WNC Berlin, 2 to 4 March 2027.
Click Here to Register Now.

‍

Regulatory Scientist, Womble Bond Dickinson

Cheryl K. Olson, MPH, Sc.D. is a behavioral scientist internationally recognized for her work on tobacco harm reduction and the influence of media on youth. She earned a Doctor of Science degree in health and social behavior from the Harvard School of Public Health.

Dr. Olson has worn many hats in her career, from running a research center on mental health and media at Massachusetts General Hospital/Harvard Medical School, to writing popular and academic books and creating TV/radio content on health topics, to conducting studies on perceptions and intentions of reduced-risk nicotine products. Her research often focuses on vulnerable groups, such as people in custody or older persons who smoke. Now a Regulatory Scientist at Womble Bond Dickinson, Dr. Olson is based in Richmond, Virginia, USA.

By 
WNC Team

Featured Events

2 March 2027
02
 – 
04 March 2027

WNC Berlin 2027

Berlin, Germany
A three-day forum bringing together senior leaders from industry, politics, finance, and public health to explore the evolving world of nicotine.